New treatment for depression

Israel’s PsyRx has developed a radically new treatment for depression. It combines an approved medicine from the SSRI family with a low dosage of ibogaine. PsyRx has just completed a successful lab toxicological safety study for the treatment to help it progress to human trials.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *